A patient-initiated treatment model for blepharospasm and hemifacial spasm: a randomized controlled trial

A patient-initiated treatment model for blepharospasm and hemifacial spasm: a randomized controlled trial

Background: To test, in a two-arm, single center, superiority, randomized controlled trial, the effectiveness of and costs associated with a patient-initiated treatment model for people with hemifacial spasm (HFS) and blepharospasm (BEB) in comparison to usual care. Methods: One hundred and thirty p...

Full description

Bibliographic Details
Main Authors: Brini, S. (Author), Crampton, B. (Author), Dunlop, N. (Author), Ezra, D.G (Author), Flood, C. (Author), Hirani, S.P (Author), Hurt, C.S (Author), Lawes-Wickwar, S. (Author), McBain, H. (Author), Newman, S.P (Author), Solly, D. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
adolescent
Adolescent
adult
aging
anxiety disorder
Article
blepharospasm
Blepharospasm
Blepharospasm Disability Index
Botulinum toxin
botulinum toxin A
Botulinum Toxins, Type A
clinical effectiveness
comparative study
controlled study
depression
disability
disease severity
Dystonia
economic aspect
female
health care cost
Health Care Costs
health care personnel
hemifacial spasm
Hemifacial spasm
Hemifacial Spasm
hospital management
human
Humans
Jankovic Rating Scale
major clinical study
male
middle aged
patient care
patient satisfaction
Patient-initiated services
quality of life
Quality of Life
randomized controlled trial
Randomized controlled trial
scoring system
teleconsultation
treatment outcome
unemployment
United Kingdom
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items